Loading...

Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 4.98 USD -0.4% Market Closed
Updated: Dec 8, 2022

Intrinsic Value

The intrinsic value of one GDRX stock under the Base Case scenario is 8.1 USD. Compared to the current market price of 4.98 USD, Goodrx Holdings Inc is Undervalued by 39%.

The Intrinsic Value is calculated as the average of the two valuation methods:

GDRX Intrinsic Value
Base Case
8.1 USD
Undervaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

GDRX Profitability Score
Profitability Due Diligence

Goodrx Holdings Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROE
Negative 3-Year Average ROIC
Negative Net Income
Positive Operating Income
40/100
Profitability
Score

Goodrx Holdings Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

GDRX Solvency Score
Solvency Due Diligence

Goodrx Holdings Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Average Interest Coverage
Low Altman Z-Score
Low D/E
Negative Net Debt
44/100
Solvency
Score

Goodrx Holdings Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
92%
Gross Margin
4%
Operating Margin
-9%
Net Margin
15%
FCF Margin
-9%
ROE
26%
ROIC
Other

GDRX Capital Structure
Goodrx Holdings Inc

Market Capitalization 2B USD
Total Debt 653M USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 729M USD
Short-Term Investments 0 USD
Enterprise Value 1.9B USD

Wall St
Price Targets

GDRX Price Targets Summary
Goodrx Holdings Inc

Wall Street analysts forecast GDRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GDRX is 7.25 USD with a low forecast of 4.55 USD and a high forecast of 11.55 USD.

Lowest
Price Target
4.55 USD
9% Downside
Average
Price Target
7.25 USD
46% Upside
Highest
Price Target
11.55 USD
132% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

GDRX Competitors
Goodrx Holdings Inc

GDRX Suppliers & Customers
Goodrx Holdings Inc

There is no information about
Goodrx Holdings Inc
key suppliers

Goodrx Holdings Inc has 6 key customers from 1 countries and 4 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Technology industry.

Ownership

GDRX Insider Trading
Buy and sell transactions by insiders

Goodrx Holdings Inc insiders have only sold shares in the past 12 months.

During the last 12 months Goodrx Holdings Inc insiders have not bought any shares, and sold 43M USD worth of shares. The last transaction was made on Dec 8, 2022 by Slutsky Andrew (President, Consumer), who sold 1.2M USD worth of GDRX shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
36.3M USD
6
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
N/A
N/A
N/A
6 Months
N/A
N/A
N/A
9 Months
N/A
N/A
N/A
12 Months
36.3M USD
N/A
-36.3M
Purchases
11
Sales
85
Why is insider trading important?

Shareholder Return

GDRX Price
Goodrx Holdings Inc

1M 1M
-5%
6M 6M
-31%
1Y 1Y
-88%
3Y 3Y
-90%
5Y 5Y
-90%
Annual Price Range
4.98
52w Low
4.06
52w High
41.61
Price Metrics
Average Annual Return -17.52%
Standard Deviation of Annual Returns
N/A
Max Drawdown -93%
Shares Statistics
Market Capitalization 2B USD
Shares Outstanding 398 126 428
Percentage of Shares Shorted 16.29%

Company Profile

Goodrx Holdings Inc

Country

United States of America

Industry

Health Care

Market Cap

2B USD

Dividend Yield

0%

Description

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 756 full-time employees. The company went IPO on 2020-09-23. The firm provides GoodRx platform, which aggregates and analyzes pricing data from a number of different sources. Its platform also provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharmaceutical manufacturer solutions offering provides advertising and integrated consumer affordability solutions to pharmaceutical manufacturers.

Contact

CALIFORNIA
Santa Monica
2701 Olympic Boulevard, Suite 990
+18552682822.0
https://investors.goodrx.com/

IPO

2020-09-23

Employees

756

Officers

Co-founder, Co-CEO & Director
Mr. Douglas Joseph Hirsch
Co-founder, Co-CEO, Sec. & Director
Mr. Trevor Bezdek
CFO & Principal Financial Officer
Mr. Karsten Ian Voermann
Chief Marketing Officer and SVP of Marketing & Communications
Mr. Babak Azad
Pres of Healthcare
Mr. Bansi Nagji
Chief Operating Officer
Mr. Raj Beri
Show More
Chief Accounting Officer & Principal Accounting Officer
Mr. Romin Nabiey
VP of Investor Relations
Ms. Whitney Notaro
Chief People Officer
Ms. Vina M. Leite
Sr. VP of Corp. Strategy & Bus. Operations
Mr. Justin Fengler
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one GDRX stock?

The intrinsic value of one GDRX stock under the Base Case scenario is 8.1 USD.

Is GDRX stock undervalued or overvalued?

Compared to the current market price of 4.98 USD, Goodrx Holdings Inc is Undervalued by 39%.